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Abstract
Background: Use of information campaigns and educational interventions directed to citizens and supported by
physicians, aimed at promoting the appropriate use of medicines, have been evaluated by several studies with
conflicting results. These interventions are potentially relevant, favouring the reduction of unnecessary use of
medicines and related risks. Several studies have specifically evaluated the promotion of the appropriate use of
antibiotics in adults and children, with variable results. A controlled study is proposed to evaluate the feasibility
and effectiveness of a multifaceted intervention aimed at reducing antibiotic prescription by increasing awareness
on risks of their unnecessary use.
Methods/design: Information will be provided to citizens through several media (posters, local TV, radio and
newspapers, video terminals, websites of Local Health Authorities). Brochures with information on expected
benefits and risks of antibiotics will be also available, either with direct access in waiting rooms and pharmacies or
handed out and mediated by doctors. Physicians and pharmacists will get specific data on local antibiotic
resistance. A small group of representative doctors have also actively participated in defining the campaign key
messages. A sample of general practitioners and paediatricians will be trained in patient counselling strategies.
The information campaign will be implemented in two Provinces of Emilia-Romagna during the fall-winter season
(November 2011-February 2012). Change in the overall prescribing rate of antibiotics (expressed as DDD per 1000
inhabitants/day) in the intervention area will be compared versus other areas in the same Region. Knowledge and
attitudes of the general population will be evaluated through a phone and internet survey on a representative
sample.
Discussion: While the campaign messages will be mainly directed to the general population, doctors’ prescribing
will be assessed. The main rationale for this apparent discrepancy lies in the influence patients may have on
physicians’ prescribing behaviour (directly or indirectly) and in physicians’ endorsement of the campaign goals,
considering their participation in its design.
This study could observe a reduction lower than 5% in the prescribing rate of antibiotics. Such a reduction would
be of public health relevance and would determine average savings of almost twice as much as the campaign
costs.
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Background
Use of information campaigns and educational interven-
tions directed to citizens and supported by physicians,
aimed at promoting the appropriate use of medicines,
have been evaluated by several studies with conflicting
results. Evaluating the feasibility and effectiveness of
these interventions is relevant, considering the influence
citizens may have on physicians’ prescribing habits, both
directly (when patients request prescription filling) and
indirectly (when physicians think their patients expect
getting a prescription) [1]. Physicians could also be moti-
vated in their prescribing behaviour by the implementa-
tion of information campaigns, especially if their active
participation is requested [2]. Analysing population tar-
gets, campaign methods and available experiences can
provide useful information for planning this kind of
intervention, which may determine potentially relevant
contributions to public health by reducing unnecessary
use of medicines and related risks.
As for population targets: citizens are exposed to several
information sources about the effects of medicines, either
through traditional media (TV, journals, radio, etc) or
through the internet with its constant evolution to more
interactive tools (blogs and the many features of web 2.0).
These information are often promoted by drug producers:
in Europe, direct-to-consumer drug advertising is cur-
rently not allowed (although the European Commission is
considering a worrisome proposal to relax this ban) [3]
but citizens may be exposed to web contents and, above
all, to information promoted by people and institutions
sponsored by drug companies, also available through tra-
ditional media [4]. These circumstances can favour a
biased view of benefits and risks of treatments. Informa-
tion promoted by public health institutions has generally a
weaker potential, since resources and planning are most of
the times inadequate if compared with commercially
oriented information. Adequate planning of public health
initiatives and allocation of economic as well as human
resources are necessary in order to provide citizens with
an evidence-based, unbiased view of benefits and risks of
drug treatments, and to favour their appropriate use.
Several studies have shown the potential of mass media
on the use of health interventions [5]. Medicines represent
a relatively fortunate topic for a public health information
campaign: maybe, suggesting to use medicines wisely in
view of their benefits and risks can influence behavioural
change more than suggesting the adoption of healthy life-
styles, uneasy to practise in spite of their well known
benefits.
Aside from the specific topic focused on, many other
variables may influence the effectiveness of multifaceted
educational campaigns. Defining one or more relevant
target audiences and key messages are essential elements.
A thorough evaluation of local contexts and a wise mix
of information tools is necessary as well, taking lessons
from those who do commercial information and advertis-
ing. ‘’Social marketing’’ techniques may help the promo-
tion of evidence-based knowledge. This term refers to
the application of marketing techniques to the solution
of social and health problems [6]. A social marketing
approach to evidence-based information could take into
account a planning process involving ‘’consumer’’
oriented research, objective setting, identification of bar-
riers and, consequently, of strategies and tools to facili-
tate the transfer of key messages
As for doctor’s role: information campaigns could be
more effective if physicians facilitate the transmission of
information to their patients [7]. In order this potential
to be unfolded, it may be necessary to work on doctors’
motivations and skills in better conveying information to
their patients, in spending some more time and energy to
evaluate patients’ expectations, possible obstacles to atti-
tudinal and behavioural changes and eventually to find
the right keys motivating them to such changes.
Practicing physicians can also provide substantial help in
developing campaign messages, since they are in a relevant
position to evaluate comprehensibility and potential effects
of specific information in the context of patient expecta-
tions in primary care. Such participation can also increase
their sense of ownership of the campaign goals and facili-
tate their endorsement [2], which can ultimately lead to
increased attention to appropriate prescribing. Lastly, doc-
tors may be influenced by the awareness that patients
could be more informed about (and more sensitive to) the
campaign topic [8].
Several studies have evaluated the effects of educational
interventions focused on the appropriate use of antibio-
tics in adults and in children. A Cochrane systematic
review, reporting the results of 39 among RCTs and
observational studies [9], showed that such interventions
can be successful especially when local context and bar-
riers are adequately analyzed and addressed. Specifically,
multifaceted interventions involving both physicians and
patients/public, using written information material, edu-
cational meetings and mass media seem moderately
effective, more than single interventions, in decreasing
antibiotic prescribing for inappropriate indications (range
of absolute differences: 3-33%); only one of these studies,
carried out in Finland, showed a reduction in antibiotic
resistance (erythromycin resistance was halted in four
years). Another systematic review published in 2008,
reporting the results of 43 among RCTs and observa-
tional studies, showed that educational strategies invol-
ving physicians (in particular active education through
seminars and visits) and patient education strategies
(through written material and mass media) are moder-
ately effective in reducing unnecessary antibiotic use
(median absolute difference: 10%) [10]. Several studies
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evaluating the impact of regional and national informa-
tion campaigns on antibiotic use are available, carried
out especially in Australia [11,12] and the United States
[13-15], but also in Europe (for example in France [16]).
In selected cases, a favourable cost effectiveness ratio was
shown [13]. A recent survey under the auspices of the
European Commission revealed that information cam-
paigns may change people’s behaviour in terms of anti-
biotic use: more than one out of 10 people remember to
have received information on this issue and are willing
not to take antibiotics without talking to a doctor [17].
Definitively, there seems to be room for improving citi-
zens’ knowledge about the correct use of antibiotics.
Within a wider project called ProBA project (progetto
Bambini Antibiotici), in 2003 the Health Agency of the
Emilia-Romagna Region carried out a survey on 633
paediatricians (453 working as family paediatricians and
180 working in hospitals) and 1388 parents, aimed at
evaluating the main determinants of antibiotic prescrip-
tions for children [18]. This survey showed that improv-
ing paediatricians’ and parents’ knowledge on benefits
and risks of antibiotics, and suggesting that resistance is
a problem at the community but also at the individual
level, may favour their more appropriate use.
Starting from these considerations and from local and
international experiences on educational campaigns, we
propose a study to evaluate the feasibility and effective-
ness of a multifaceted intervention on antibiotic pre-
scription in the general population, aimed at reducing it
by increasing awareness on risk of unnecessary use, thus
reducing patients’ requests for unnecessary prescription.
The specific objectives are:
• primarily, to reduce the overall volume of antibio-
tic prescription;
• secondarily, to reduce total costs associated to
antibiotic prescriptions; to evaluate knowledge, atti-
tudes and reported behaviours of a sample of citi-
zens on benefits and risks of antibiotic use; and to
evaluate trends in antibiotic resistance (in a three
year period after the intervention) from sputum,
throat swab, urine and blood samples
We consider such intervention of high public health
relevance, considering the limited development of new
antibiotics and the public health threat due to antibiotic
resistance, which is in part accounted for antibiotic use in
humans. The proposed intervention will involve citizens,
general practitioners and paediatricians in two Provinces
of Emilia-Romagna. In addition to promoting the appro-
priate use of antibiotics, this project will help to evaluate
the feasibility of carrying out information campaigns on
benefits and risks of medicines promoted by Local Health
Authorities, with the collaboration of local physicians.
Methods/design
This study will be a community level, controlled, non
randomized trial. An information campaign on benefits
and risks of antibiotic use, in general and specifically in
upper respiratory infections, will be implemented in the
provinces of Modena and Parma, in the Emilia-Romagna
region. Regional areas where no campaign will be imple-
mented and no information provided to physicians either
will be the control group; the presence of local policies
on antibiotics that would possibly alter the comparison
with intervention areas will be evaluated immediately
before implementing the campaign, so that provinces
which may supply misleading data would not be included
in the control group. Anyway, prescription of antibiotics
in the intervention and control areas shall be similar at
baseline (no statistically significant differences).
Considering that the proposed educational intervention
will be done at the community level and will be multifa-
ceted using several media, and considering its implemen-
tation in only two provinces, we think a randomised
design would not add strength to the study validity: in
fact, it would be impossible to restrict exposure to half
the population and there would be too few units of ran-
domisation. Therefore, we choose a non randomised
design which is more feasible given those circumstances.
Study population
The proposed multifaceted intervention will target adult
citizens and physicians. Specifically, citizens will be
directly targeted by general information through bro-
chures, posters and mass media. General practitioners
and paediatricians will receive ad hoc information on
antibiotic resistance and will have an active role in facili-
tating the campaign messages getting through, so that
they may be also sensitized to the issue of appropriate
antibiotic prescribing (Table 1).
Intervention/exposure
The campaign will be generally focused on the appropri-
ate use of antibiotics in upper respiratory tract infec-
tions. Problems arising from antibiotic overuse, in
particular antibiotic resistance, will be particularly
pointed at. On the other side, it will be highlighted that
antibiotics are necessary in specific circumstances and
should be used when doctors say it. The main instru-
ments of the proposed multifaceted intervention are dis-
cussed as follows.
1. Written information material (brochures) targeted
at the general population. Specifically, two different
types of brochure will be available: type-A brochure will
provide general information on benefits and risks of
antibiotic therapies; type-B brochures will provide more
specific information on three possible clinical situations
patients (and doctors) may deal with: antibiotic is
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necessary and is prescribed; antibiotic is not necessary
and is not prescribed; antibiotic may or may not be
necessary, so that a “wait and see” period is warranted.
In developing the specific messages, particular attention
has been given to the evaluation of key determinants of
potentially inappropriate antibiotic use. The occurrence of
antimicrobial resistance both at population and individual
level, and of side effects, will be particularly targeted. In
this regard, the relevance of antibiotic prescribing on indi-
vidual resistance has been further highlighted by a recent
systematic review and meta-analysis [19]. A small group of
representative physicians (one per Health District,
appointed by their Local Health Authorities) helped iden-
tifying the campaign key messages in order to maximize
their relevance to the target audiences. Attention will be
also given to the editorial appeal and clarity, borrowing
communication techniques from commercial marketing to
construct an attractive, concise, easy-to-read and recall
format.
The brochures will be available in waiting rooms of gen-
eral practices and local health services (type-A) and will be
distributed to patients by general practitioners and paedia-
tricians (type-B). Electronic versions will be available on
the web. Translated versions in Albanian, Arab, Chinese,
English, French, Polish, Rumanian, Russian will be also
posted on the web, so that doctors could print them out
to share information with their foreign patients (mostly
immigrants).
2. Posters developed through the same methodology as
described above (see point 1). Given the nature of this
media, specific attention has been given to focusing on
few clear messages. Posters will be mainly available in gen-
eral practices, pharmacies and local health services.
3. Short videos to be transmitted through video term-
inals in highly accessed places (mainly pharmacies and
waiting rooms in surgeries/health services), local TVs
and websites of Local Health Authorities.
4. Radio-spots to be transmitted in local radio stations
5. Advertisements and concise articles in local news-
papers, written in a scientifically sound but accessible
way to the average reader.
6. Web materials/banners in web sites of local
newspapers.
7. A newsletter on antibiotic resistance in Emilia-
Romagna, available to physicians and pharmacists in the
intervention areas.
8. Training courses in counselling strategies, directed
to general practitioners and paediatricians to facilitate
information transfer on the campaign contents. More
specifically, all general practitioners and paediatricians
in the intervention areas will get a half-day presentation
about the campaign and its instruments, discussing the
importance of counselling strategies through examples
relevant to the antibiotics campaign. A six-module
course will be pilot-tested on about 120-150 physicians
on a voluntary basis during the campaign implementa-
tion, to improve their ability to convey information and
facilitate their patients’ behavioural change.
The proposed interventions will be implemented dur-
ing a 4 month period (November 2011 - February 2012).
Primary Outcome
Cumulative five-month (November to March) changes
in prescribing rates of specific classes of antibiotics in
general practice, expressed as DDD per 1000 inhabi-
tants/day.
Data on antibiotic prescriptions (on beta-lactams,
cephalosphorins, macrolides, fluoroquinolones, corre-
sponding to J01C, J01D, J01F, J01M atc codes) will be
retrieved from regional prescribing databases. They will
include NHS prescriptions only from general practi-
tioners (a small part of prescriptions may be made out-
side NHS on personal prescription books) and will not
assess the actual use of antibiotics. In Emilia-Romagna,
prescriptions from paediatricians are expressed in pieces
and not in DDD, and will be evaluated separately.






KNOWLEDGE Awareness of the antibiotic resistance issue and of the importance of a
correct use of antibiotics (through brochures, posters and mass-media)
Awareness of local data on antibiotic
resistance (through a newsletter)
ATTITUDE Awareness that antibiotics are not a panacea, but their use is
fundamental in specific circumstances
• Sensitization to the issue of appropriate
antibiotic prescribing
• Perception that patients may be more
informed about (and more sensitive to) the
antibiotic resistance issue
BEHAVIOUR • Lower pressure on doctors to get antibiotics Appropriate antibiotic prescribing
• Less antibiotic self-use
• More appropriate use
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Secondary outcomes
- changes in antibiotic prescribing trends in eighteen
months
- changes in antibiotic expenditure per 1000 inhabi-
tants/day (comparing to the same November to March
period from the previous year)
- knowledge of and attitudes about the campaign mes-
sages, through a telephone and internet survey on a
sample of the target population.
As for trends in antibiotic resistance, the regional anti-
biotic surveillance system regularly monitors and will keep
monitoring antibiotic resistance through the analysis of
blood, throat swab and sputum samples. Considering this
circumstance, data about antibiotic resistance will be eval-
uated in a three year period after the intervention.
Sample size calculation
In the first three months of 2011, antibiotic prescribing
rate in the provinces chosen as possible intervention areas
was 21,1 DDD per 1000 inhabitants/day. Ratio of prescrib-
ing rates in intervention vs other Provinces in Emilia-
Romagna was 1. Standard deviation of the distribution of
antibiotic prescribed by general practitioners was about
3,0 in a 2007 dataset of antibiotic prescriptions in the pro-
vince of Modena. Assuming that ratio of prescribing rates
has not changed, that standard deviation of antibiotic pre-
scription is 6,0 (a very conservative doubled figure com-
pared to the 2007 sample) and that is similar in exposed
and not exposed areas, it will be possible to observe tiny
reductions of antibiotic prescription, and surely meaning-
ful reductions of at least 3-5%, with alfa = 5% and beta =
10%. Potential average economic savings of such reduc-
tions would more than offset the fund received to finance
the campaign and would be more than three times the
out-of-pocket expenses to implement the campaign.
Statistical analysis
T-test (for continuing variables), chi-square test (for dis-
crete variables), time series analysis and multiple linear
regression will be used, the latter to investigate in second-
ary analyses how specific variables (baseline prescriptions,
province, health district, size of assisted population) can
affect outcomes. Analysis of covariance (ANCOVA) will
be used for evaluating primary outcomes in case relevant
baseline imbalances will make statistical adjustment
necessary.
Ethics approval
The protocol has been approved by the provincial ethics
committees of Modena and Parma
Discussion
This study will explore the impact of a local multifaceted
information campaign on antibiotics. While the
campaign messages will be mainly directed to the general
population, volume of antibiotics prescribed (therefore
doctors’ prescribing behaviour) will be the main outcome
of interest. Three points make the rationale for this
apparent discrepancy and for the relevant role that
informing patients may play: prescribers may be influ-
enced by actual or perceived patient pressure to get anti-
biotics; they may be influenced by the awareness that
patients may be more informed about (and more sensi-
tive to) the antibiotic resistance issue; they have been
asked to actively participate in developing the campaign
messages and facilitating their transmission to patients,
so that their endorsement of the campaign goals may be
more likely. Thus, the “complex” nature of the proposed
intervention lies not only in the use of multiple instru-
ments, but especially in such articulate interplay between
targets of information and targets of behavioural change,
mirroring some of the possible influences on drug pre-
scription in clinical practice.
The potential impact of such a low-cost multifaceted
intervention implemented within Local Health Authori-
ties and using local media is of general interest, as well
as its feasibility. One further reason of interest is that, in
Italy, data are lacking about the impact of information
campaigns addressing health topics, especially if “hard”
outcomes (such as drug prescribing) are considered.
The likely presence of a parallel national campaign
implemented in the same period (as it was in 2009 and
2010, part of a European initiative) could theoretically
weaken the potential impact of this intervention; on the
other side, we would be more confident if any effect had
to be shown and the added value of a local initiative,
with the use of local media and especially the participa-
tion of physicians, would be further elucidated.
As for ethical aspects, the information campaign will
provide general, clear and carefully balanced messages
explaining when antibiotics are necessary and risks of
their unnecessary use. This information is expected to
increase appropriate use of antibiotics and, ultimately,
health of the exposed population. Since doctors (in par-
ticular general practitioners) will have a fundamental
role in mediating this information, the risk of its incor-
rect interpretation will be very limited.
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